Journal article Open Access

OFLOXACIN (ANTI-BACTERIAL DRUG)

Gharmalkar Samruddhi .K*, Prof. A.L. Ware

Ofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic acid. It is orally administrated broad spectrum anti-bacterial & some anaerobes. Moreover ofloxacin achieves high concentration in most tissues and body fluids. The result of clinical trials with ofloxacin have confirmed the potential for use in a wide range of infections, which was indicated by its in vitro anti-bacterial & pharmacokinetics profiles. It has proven effective against a high percentage of infection caused by gram-negative organisms, slightly less effective against gram positive infections, & effective against some anaerobic infections. Ofloxacin is well tolerated & although experience with the drug in clinical practices to date is limited, bacterial resistance does not appear to develop readily. Thus, ofloxacin is an orally active drug which offers a valuable alternative to other broad spectrum anti-bacterial drug. The synythesis of Ofloxacin was carried out in this article. And quinoline-4(1H)-one is the intermediate that was found in this Ofloxacin. There physiochemical properties & characterization of impurity is also described.

Files (1.3 MB)
Name Size
210602.pdf
md5:90f7042061ef81ad6f33a8f2009c1294
1.3 MB Download
26
13
views
downloads
All versions This version
Views 2626
Downloads 1313
Data volume 16.7 MB16.7 MB
Unique views 2525
Unique downloads 1313

Share

Cite as